In SIgAD patients with concomitant autoimmune diseases, decreased expression levels of genes related to the type I interferon (IFN) pathway, including IFIT1, MX1, IFI6, and IFI44L, were observed. This evidence concerns the gene IFNA1 and autoimmune disease.